230 related articles for article (PubMed ID: 18644692)
21. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy.
Kuru B
Singapore Med J; 2011 Apr; 52(4):289-98. PubMed ID: 21552792
[TBL] [Abstract][Full Text] [Related]
23. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
[TBL] [Abstract][Full Text] [Related]
24. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
25. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
de Bock GH; Putter H; Bonnema J; van der Hage JA; Bartelink H; van de Velde CJ
Breast Cancer Res Treat; 2009 Sep; 117(2):401-8. PubMed ID: 19148746
[TBL] [Abstract][Full Text] [Related]
26. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
27. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
[TBL] [Abstract][Full Text] [Related]
28. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Peintinger F; Symmans WF; Gonzalez-Angulo AM; Boughey JC; Buzdar AU; Yu TK; Hunt KK; Singletary SE; Babiera GV; Lucci A; Meric-Bernstam F; Kuerer HM
Cancer; 2006 Sep; 107(6):1248-54. PubMed ID: 16862596
[TBL] [Abstract][Full Text] [Related]
29. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
[TBL] [Abstract][Full Text] [Related]
30. Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger.
Lammers EJ; Huibers P; van der Sangen MJ; van de Poll-Franse LV; Poortmans PM; Ernst MF; Lemaire BM; Meijs CM; Nuytinck HK; Voogd AC
Breast; 2010 Feb; 19(1):44-9. PubMed ID: 19913419
[TBL] [Abstract][Full Text] [Related]
31. Locoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?
Trovo M; Durofil E; Polesel J; Roncadin M; Perin T; Mileto M; Piccoli E; Quitadamo D; Massarut S; Carbone A; Trovo MG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e153-7. PubMed ID: 22386375
[TBL] [Abstract][Full Text] [Related]
32. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?
Oh JL; Bonnen M; Outlaw ED; Schechter NR; Perkins GH; Strom EA; Babiera G; Oswald MJ; Allen PK; Thames HD; Buchholz TA
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1345-52. PubMed ID: 16750315
[TBL] [Abstract][Full Text] [Related]
33. Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.
van Nes JG; Putter H; van Hezewijk M; Hille ET; Bartelink H; Collette L; van de Velde CJ;
Eur J Surg Oncol; 2010 Jul; 36(7):617-24. PubMed ID: 20558026
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs adjuvant systemic treatment?
Yildirim E; Berberoglu U
Neoplasma; 2007; 54(4):353-8. PubMed ID: 17822326
[TBL] [Abstract][Full Text] [Related]
35. Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.
Livi L; Saieva C; Paiar F; Simontacchi G; Galardi A; De Luca Cardillo C; Mangoni M; Paoletti L; Ponticelli P; Biti GP
Eur J Surg Oncol; 2007 Apr; 33(3):271-5. PubMed ID: 16831531
[TBL] [Abstract][Full Text] [Related]
36. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Mansell J; Monypenny IJ; Skene AI; Abram P; Carpenter R; Gattuso JM; Wilson CR; Angerson WJ; Doughty JC
Breast Cancer Res Treat; 2009 Sep; 117(1):91-8. PubMed ID: 19112615
[TBL] [Abstract][Full Text] [Related]
37. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
[TBL] [Abstract][Full Text] [Related]
38. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
39. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Blakely LJ; Buzdar AU; Lozada JA; Shullaih SA; Hoy E; Smith TL; Hortobagyi GN
Cancer; 2004 Feb; 100(3):465-9. PubMed ID: 14745861
[TBL] [Abstract][Full Text] [Related]
40. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
